Jason J. Davis

Jason J. Davis

Auto-generated profile, based on publicly available information

Jason J. Davis

Department of Orthopaedic Surgery, Henry Ford Hospital, Detroit, MI

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2017 in Arthroplasty Today
Verified
Journal Article
Open access
NFNicholas B. Frisch
Nicholas B. Frisch
OKOmar M. Kadri
Omar M. Kadri
TTTroy Tenbrunsel
Troy Tenbrunsel
AAAbraham Abdul-Hak
Abraham Abdul-Hak
MQMossub Qatu
Mossub Qatu
JDJason J. Davis
Jason J. Davis
Surgical site irrigation during total hip (THA) and total knee (TKA) arthroplasty is a routine practice among orthopaedic surgeons to prevent periprosthetic joint infection. The purpose of this study was to evaluate the effect of chlorhexidine gluconate (CHG) irrigation on infection rates following THA and TKA. Arthroplasties performed before September 2014 served as controls. THA performed before September 2014 (N = 253) underwent intraoperative irrigation with 0.9% saline followed by a 2-minute soak with <2% dilute povidone-iodine. TKA (N = 411) patients underwent only intraoperative saline irrigation. After October 2014, all patients (248 TKA and 138 THA) received intraoperative irrigation with 0.9% saline and periodic 0.05% CHG solution followed by a final 1-minute soak in CHG with immediate closure afterward. In this 2:1 comparison of consecutive patients, there were no differences in patient demographics between the 2 groups. No difference was noted in wound healing concerns subjectively, and no statistically significant association in nonsurgical site infections, superficial surgical site infection, and deep surgical site infection rates between the 2 groups (nonsurgical site infections [THA: P = .244, TKA: P = .125]; superficial surgical site infection [THA: P = .555, TKA: P = .913]; and deep surgical site infection [THA: P = .302, TKA: P = .534]). We were unable to discern a difference in infection rates between chlorhexidine irrigation and our prior protocols using dilute Betadine for THA and 0.9% saline for TKA. The theoretic advantages of dilute CHG retention during closure appear to be safe without infectious concerns.

2 January 2019 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
KSKaran Srivastava
Karan Srivastava
KBKevin J. Bozic
Kevin J. Bozic
CSCraig Silverton
Craig Silverton
ANAndrew J. Nelson
Andrew J. Nelson
EMEric C. Makhni
Eric C. Makhni
JDJason J. Davis
Jason J. Davis
Background: Periprosthetic joint infection (PJI) following total knee arthroplasty is a growing concern, as the demand for total knee arthroplasty (TKA) expands annually. Although 2-stage revision is considered the gold standard in management, there is substantial morbidity and mortality associated with this strategy. One-stage revision is associated with lower mortality rates and better quality of life, and there has been increased interest in utilizing the 1-stage strategy. However, surgeons are faced with a difficult decision regarding which strategy to use to treat these infections, considering uncertainty with respect to eradication of infection, quality of life, and societal costs with each strategy. The purpose of the current study was to use decision analysis to determine the optimal decision for the management of PJI following TKA. Methods: An expected-value decision tree was constructed to estimate the quality-adjusted life-years (QALYs) and costs associated with 1-stage and 2-stage revision. Two decision trees were created: Decision Tree 1 was constructed for all pathogens, and Decision Tree 2 was constructed solely for difficult-to-treat infections, including methicillin-resistant infections. Values for parameters in the decision model, such as mortality rate, reinfection rate, and need for additional surgeries, were derived from the literature. Medical costs were derived from Medicare data. Sensitivity analysis determined which parameters in the decision model had the most influence on the optimal strategy. Results: In both decision trees, the 1-stage strategy produced greater health utility while also being more cost-effective. In the Monte Carlo simulation for Decision Trees 1 and 2, 1-stage was the dominant strategy in about 85% and 69% of the trials, respectively. Sensitivity analysis showed that the reinfection and 1-year mortality rates were the most sensitive parameters influencing the optimal decision. Conclusions: Despite 2-stage revision being considered the current gold standard for infection eradication in patients with PJI following TKA, the optimal decision that produced the highest quality of life was 1-stage revision. These results should be considered in shared decision-making with patients who experience PJI following TKA. Level of Evidence: Economic and Decision Analysis Level IV. See Instructions for Authors for a complete description of levels of evidence.

1 May 2016 in The Journal of Arthroplasty
Verified
Journal Article
Closed access
WNWayne T. North
Wayne T. North
NMNima Mehran
Nima Mehran
JDJason J. Davis
Jason J. Davis
CSCraig D. Silverton
Craig D. Silverton
RWRobb M. Weir
Robb M. Weir
MLMichael W. Laker
Michael W. Laker

1 June 2018 in The Journal of Arthroplasty
Verified
Journal Article
Closed access
MMM. Chad Mahan
M. Chad Mahan
TJToufic R. Jildeh
Toufic R. Jildeh
TTTroy N. Tenbrunsel
Troy N. Tenbrunsel
JDJason J. Davis
Jason J. Davis

1 June 2019 in Arthroplasty Today
Verified
Journal Article
Open access
MMM. Chad Mahan
M. Chad Mahan
TJToufic R. Jildeh
Toufic R. Jildeh
TTTroy Tenbrunsel
Troy Tenbrunsel
BABruce T. Adelman
Bruce T. Adelman
JDJason J. Davis
Jason J. Davis
Mepivacaine as an intermediate-length spinal anesthetic for rapid recovery in total knee arthroplasty (TKA) has not been fully described. We compared spinal mepivacaine vs bupivacaine for postoperative neurologic function in patients undergoing primary TKA. Thirty-two patients undergoing primary TKA were enrolled. Primary outcome measure was return of motor and sensory function. Secondary outcome measures included assessment of urinary function, pain via visual analog scale (VAS) scores, opioid usage, distance walked and pain with physical therapy, time to discharge readiness, and complications. Patients with mepivacaine spinal anesthetic had faster return of sensory function (164 ± 38.6 vs 212 ± 54.2 minutes, P = .015), return of motor function (153 ± 47.4 vs 200 ± 45.2 minutes, P = .025), and time to straight leg raise (148 ± 43.5 vs 194 ± 50.8 minutes, P = .023). The mepivacaine group experienced significantly fewer episodes of urinary retention and shorter time to urination (344 ± 154.4 vs 416 ± 96.3 minutes, P = .039). Patients exhibited slightly higher VAS pain scores in the postanesthesia care unit (1.0 ± 1.7 vs 2.7 ± 2.3, P = .046) with no difference in opioid consumption. There were no differences in VAS scores or opioid use on the inpatient ward. Patients achieved discharge readiness 71 minutes faster in the mepivacaine group. There was no need to convert to general anesthesia or transient nerve symptoms in either group. Patients undergoing TKA with mepivacaine spinal anesthetic had a reliably more rapid neurologic recovery after TKA compared to bupivacaine.

1 July 2021 in The Journal of Arthroplasty
Verified
Journal Article
Closed access
JSJonathan H. Shaw
Jonathan H. Shaw
KLKevin G. Lindsay-Rivera
Kevin G. Lindsay-Rivera
PBPatrick J. Buckley
Patrick J. Buckley
RWRobb M. Weir
Robb M. Weir
TBTrevor R. Banka
Trevor R. Banka
JDJason J. Davis
Jason J. Davis